Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
189 hedge funds and large institutions have $640M invested in Immunogen Inc in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 52 reducing their positions, and 26 closing their positions.
37% more capital invested
Capital invested by funds: $468M → $640M (+$172M)
25% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 52
15% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 26
11% more call options, than puts
Call options by funds: $891K | Put options by funds: $803K
2% more funds holding
Funds holding: 185 → 189 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.7M |
| 3 |
Millennium Management
New York
|
+$8.54M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.01M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$20.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$17.6M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$6.48M |
| 4 |
Renaissance Technologies
New York
|
-$5.75M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.84M |
IMGN Hedge Fund Activity: Q2 2020 in Review
189 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2020, worth a combined $640M — up 37% from $468M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new IMGN positions and 26 closed out — a net gain of 4 holders — while 65 added to existing stakes and 52 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $17.7M. The largest seller was Redmile Group, cutting an estimated $20.1M.
- 189 institutional investors held Immunogen Inc (IMGN) as of Q2 2020, up from 185 in Q1 2020.
- Funds reported $640M of Immunogen Inc stock for Q2 2020, up 37% quarter-over-quarter.
- 30 funds opened new Immunogen Inc positions in Q2 2020 and 26 closed out, a net change of +4 holders.
- The largest Immunogen Inc buyer in Q2 2020 was Wellington Management Group, an estimated $17.7M added.
- The largest Immunogen Inc seller in Q2 2020 was Redmile Group, an estimated $20.1M sold.
Based on aggregated 13F filings for Q2 2020.